Yamashita Noboru, Kaku Toshihiko, Uchino Tomoko, Isomoto Shojiro, Yoshimatsu Hironobu, Ono Katsushige
Department of Cardiovascular Science and Internal Medicine, Oita University School of Medicine, 1-1 Idaigaoka, Hasama, Yufu, Oita 879-5593, Japan.
Mol Pharmacol. 2006 May;69(5):1684-91. doi: 10.1124/mol.105.021253. Epub 2006 Jan 27.
Low-voltage-activated T-type Ca2+ channels have been recognized recently in the mechanisms underlying atrial arrhythmias. However, the pharmacological effects of amiodarone on the T-type Ca2+ channel remain unclear. We investigated short- and long-term effects of amiodarone on the T-type (Cav 3.2) Ca2+ channel. The Cav3.2 alpha1H subunit derived from human heart was stably transfected into cells [human embryonic kidney (HEK)-Cav3.2] cultured with or without 5 muM amiodarone. Patch-clamp recordings in the conventional whole-cell configuration were used to evaluate the actions of amiodarone on the T-type Ca2+ channel current (ICa.T). Amiodarone blockade of ICa.T occurred in a dose- and holding potential-dependent manner, shifting the activation and the steady-state inactivation curves in the hyperpolarization direction, when amiodarone was applied immediately to the bath solution. However, when the HEK-Cav3.2 cells were incubated with 5 microM amiodarone for 72 h, ICa.T density was significantly decreased by 31.7+/-2.3% for control,-93.1+/-4.3 pA/pF (n=8), versus amiodarone,-56.5+/-3.2 pA/pF (n=13), P<0.001. After the prolonged administration of amiodarone, the activation and the steady-state inactivation curves were shifted in the depolarization direction by -7.1 (n=41) and -5.5 mV (n=37), respectively, and current inactivation was significantly delayed [time constant (tau): control, 13.3+/-1.1 ms (n=6) versus amiodarone, 39.6+/-5.5 ms (n=6) at -30 mV, P<0.001)]. Nevertheless, short-term inhibitory effects of amiodarone on the modified T-type Cav3.2 Ca2+ channel created by long-term amiodarone treatment were functionally maintained. We conclude that amiodarone exerts its short- and long-term inhibitory actions on ICa.T via distinct blocking mechanisms.
低电压激活的T型Ca2+通道最近已被确认为心房心律失常潜在机制的一部分。然而,胺碘酮对T型Ca2+通道的药理作用仍不清楚。我们研究了胺碘酮对T型(Cav 3.2)Ca2+通道的短期和长期影响。将源自人类心脏的Cav3.2 α1H亚基稳定转染到在含或不含5 μM胺碘酮的培养基中培养的细胞[人胚肾(HEK)-Cav3.2]中。采用传统全细胞模式的膜片钳记录来评估胺碘酮对T型Ca2+通道电流(ICa.T)的作用。当将胺碘酮立即加入浴液中时,胺碘酮对ICa.T的阻断呈剂量和钳制电位依赖性,使激活曲线和稳态失活曲线向超极化方向移动。然而,当HEK-Cav3.2细胞在5 μM胺碘酮中孵育72小时后,ICa.T密度显著降低,对照组为-93.1±4.3 pA/pF(n = 8),胺碘酮组为-56.5±3.2 pA/pF(n = 13),P<0.001。长期给予胺碘酮后,激活曲线和稳态失活曲线分别向去极化方向移动了-7.1(n = 41)和-5.5 mV(n = 37),电流失活明显延迟[时间常数(tau):对照组在-30 mV时为13.3±1.1 ms(n = 6),胺碘酮组为39.6±5.5 ms(n = 6),P<0.001]。尽管如此,胺碘酮对长期胺碘酮治疗所产生的修饰型T型Cav3.2 Ca2+通道的短期抑制作用在功能上得以维持。我们得出结论,胺碘酮通过不同的阻断机制对ICa.T发挥其短期和长期抑制作用。